Dyax
Bill Cavanagh currently serves as the Associate Director of Clinical Operations at Aldeyra Therapeutics since March 2016. Prior to this role, Bill held the position of Manager of Clinical Development at Dyax. Bill Cavanagh holds a Master's degree in Leadership with a concentration in Clinical Trial Design from Northeastern University.
Dyax
Shire acquired Dyax on January 21, 2016. Following this date, this page will no longer be actively monitored. There will be no updates or responses posted on this page. Please visit Shire's LinkedIn page at https://www.linkedin.com/company/shire or www.shire.com for more information.